Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Clinical Genetics
|
March 21, 2013
Genome-wide androgenetic mosaicism
J P Johnson, J Waterson, C Schwanke, et al.
The Review of Scientific Instruments
|
November 3, 2014
Electrochemical flowcell for in-situ investigations by soft x-ray absorption and emission spectroscopy
C Schwanke, R Golnak, J Xiao, et al.
Journal of Viral Hepatitis
|
January 10, 2018
Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct-acting antivirals
A Schütz, S Moser, C Schwanke, et al.
Clinical Genetics
|
April 17, 2013
'Deletion rescue' by mitotic 11q uniparental disomy in a family with recurrence of 11q deletion Jacobsen syndrome
J P Johnson, M Haag, L Beischel, et al.
Physical Chemistry Chemical Physics : PCCP
|
September 30, 2014
The electronic structure of perfluorodecalin studied by soft X-ray spectroscopy and electronic structure calculations
T Brandenburg, M Agåker, K Atak, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
December 17, 2016
Non-clinical studies in the process of new drug development - Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies
E L Andrade, A F Bento, J Cavalli, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
October 27, 2016
Non-clinical studies required for new drug development - Part I: early in silico and in vitro studies, new target discovery and validation, proof of principles and robustness of animal studies
E L Andrade, A F Bento, J Cavalli, et al.
Journal of Virus Eradication
|
March 27, 2023
Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy
M Schwarz, C Schwarz, A Schütz, et al.
Investigational New Drugs
|
September 8, 2019
A new series of acetohydroxamates shows in vitro and in vivo anticancer activity against melanoma
Gabriela C Segat, Camila G Moreira, Evelyn C Santos, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Clinical Genetics
|
March 21, 2013
Genome-wide androgenetic mosaicism
J P Johnson, J Waterson, C Schwanke, et al.
The Review of Scientific Instruments
|
November 3, 2014
Electrochemical flowcell for in-situ investigations by soft x-ray absorption and emission spectroscopy
C Schwanke, R Golnak, J Xiao, et al.
Journal of Viral Hepatitis
|
January 10, 2018
Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct-acting antivirals
A Schütz, S Moser, C Schwanke, et al.
Clinical Genetics
|
April 17, 2013
'Deletion rescue' by mitotic 11q uniparental disomy in a family with recurrence of 11q deletion Jacobsen syndrome
J P Johnson, M Haag, L Beischel, et al.
Physical Chemistry Chemical Physics : PCCP
|
September 30, 2014
The electronic structure of perfluorodecalin studied by soft X-ray spectroscopy and electronic structure calculations
T Brandenburg, M Agåker, K Atak, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
December 17, 2016
Non-clinical studies in the process of new drug development - Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies
E L Andrade, A F Bento, J Cavalli, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
October 27, 2016
Non-clinical studies required for new drug development - Part I: early in silico and in vitro studies, new target discovery and validation, proof of principles and robustness of animal studies
E L Andrade, A F Bento, J Cavalli, et al.
Journal of Virus Eradication
|
March 27, 2023
Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy
M Schwarz, C Schwarz, A Schütz, et al.
Investigational New Drugs
|
September 8, 2019
A new series of acetohydroxamates shows in vitro and in vivo anticancer activity against melanoma
Gabriela C Segat, Camila G Moreira, Evelyn C Santos, et al.
Page
of 1